Cell and Gene Therapy Market - Industry Dynamics, Market Size, and Opportunity Forecast to 2035

Cell and Gene Therapy Market: By Therapy Type (Cell Therapy, Gene Therapy); Indication / Therapeutic Area (Oncology, Genetic Disorders, Neurological Disorders, Cardiovascular Diseases, Ophthalmology); Vector Type (Gene Delivery Method) (Viral Vectors and Non-Viral Vectors); Manufacturing Type (In-house (Biotech/Pharma-Owned Facilities), Contract Development & Manufacturing Organizations (CDMOs), Hybrid Models (e.g., early stage in-house, scale-up outsourced), Others); End User (Hospitals and Specialty Clinics (administering therapies), Academic and Research Institutes (preclinical development), Biopharma and Biotech Companies, CDMOs and CROS, Government/Public Health Bodies (NIH, EMA programs), Others); Region—Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025–2033

Cell and gene therapy market size was valued at US$ 36.5 billion in 2024 and is projected to hit the market valuation of US$ 183.1 billion by 2035 at a CAGR of 17.5% during the forecast period 2026–2035. Read More

We Are Trusted By These Great Companies!

• Last Updated: 17-Dec-2025  |  Format:  |  Report ID: AA12251611